An International Research
Consortium to Maximise
Benefits & Equity of HIV
Treatment & Care Systems

Evidence for Action has just published 7 new case studies.

• Improving children's access to research participation in poorly resourced communities (pdf, 171kb)
• Use of scored tablets of first line antiretroviral drugs in HIV-infected children in resource limited settings: Experiences from the ARROW Clinical trial (pdf, 140kb)
• Tablets are more acceptable and give fewer problems than syrups among young HIV-infected children in resource-limited settings in the ARROW trial (pdf, 151kb)
• Sexual and reproductive health rights of adolescents living with HIV (pdf, 132kb)
• Lay workers' vital roles in supporting ART rollout: Home-based care in Zambia (pdf, 154kb)
• Strengthening research capacity at the International HIV/AIDS Alliance: the role of Evidence for Action (pdf, 127kb)
• National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between context, evidence and links (pdf, 108kb)
• Development of simple and appropriate formulations for scale-up of HIV treatment for children: an example from the CHAPAS-1 trial (pdf, 139kb)
  

Effective prevention, treatment and care services are essential to reduce the appalling waste of human life due to HIV, which has killed over 25 million people since the start of the epidemic, with 2.8m dying in 2005 alone.Evidence for Action is a five-year international research programme with core funding from the UK Department for International Development. The Evidence for Action consortium focuses on HIV treatment and care systems.The goal of the research programme is to contribute to knowledge on how to design, manage and deliver comprehensive HIV treatment and care programmes in resource poor settings.

Download NEW Evidence for Action leaflet (431kb)